Physician profile
James Tidwell
NPI 1942427380
$1,401.68
in general payments reported to CMS, 2019-2025
17 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $420 · 2020: $48.34 · 2021: $246 · 2022: $250 · 2023: $144 · 2024: $165 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $437.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $314.90 | 2019-2025 | |
| Allergan, INC. | $313.80 | 2021-2022 | |
| Genentech USA, INC. | $145.06 | 2019 | |
| Pfizer INC. | $127.27 | 2023-2024 | |
| Janssen Scientific Affairs, LLC | $115.00 | 2021 | |
| Celgene Corporation | $102.66 | 2019 | |
| Merck Sharp & Dohme LLC | $51.39 | 2023-2024 | Zerbaxa, Recarbrio, Dificid |
| Glaxosmithkline, LLC. | $49.43 | 2020-2025 | Shingrix |
| Janssen Biotech, INC. | $49.16 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.89 | 2023 | Xifaxan |
| Medtronic, INC. | $19.70 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $18.15 | 2019 | |
| Polynovo North America LLC | $17.61 | 2023 | |
| Exact Sciences Corporation | $17.31 | 2024 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $15.48 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $12.70 | 2019 | |
| Merz North America, INC. | $12.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Tidwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.